The world’s largest online global summit dedicated to AI in medicine where clinicians, technologists, NGO’s and c-suite executives from all over the world come together for 3 days of exclusive talks, dynamic on-demand and live content, networking and virtual meetings to create a future where AI will revolutionize health and #saveliveswithai.
The healthcare industry is evolving rapidly with large volumes of data and increasing challenges in cost and patient outcomes. In this evolution, artificial intelligence (AI) has started playing a key role towards providing personalised patient experiences, streamlined operations and improved bottom lines.Early adopters of AI in the healthcare space are reaping the benefits in terms of patient care and adding to their bottom line results. These companies are using AI in a number of scenarios like managing claims, detecting fraud, improving clinical workflows, and predicting hospital acquired infections.
Arena International Announces the Leading Outsourcing in Clinical Trials Conference as a Virtual Experience
London – Arena International announced today that the Outsourcing in Clinical Trials Conference (https://arena-international.com/octvirtual/) will be held as a Virtual Experience on Wednesday, 27 May 2020, providing the ideal platform to talk about the impact of crisis on the pharma industry and discovering best approaches to CRO, Sponsor and Patient relationships. 2020’s Virtual edition will continue to bring engaging networking opportunities and cutting-edge content specifically for Outsourcing in Clinical Trials direct to your screen.
This marcus evans industry-working group will feature many of the ongoing constraints that are faced during the formulation development of biologics and the selection and development of drug delivery systems. From protein characterisation to QbD practices and manufacturing processes, this event will enable you to grasp the latest research, learn about novel innovative delivery platforms and be part of highly interactive discussions. Experts in the field from Big Pharma companies, Research Institutes and successful Biotech companies will lead this engaging upcoming event. We will foster stimulating conversations by creating a platform to discuss high-concentrated formulations, challenges with excipient interactions, liquid and powder formulations, several delivery systems or the feasibility of oral biologics.